AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

INTERNATIONAL BIOTECHNOLOGY TST PLC

Declaration of Voting Results & Voting Rights Announcements Nov 1, 2023

5163_rns_2023-11-01_20e80449-4ab9-4aa4-9b8a-457c0756ff4f.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 9223R

Intl. Biotechnology Trust PLC

01 November 2023

1 November 2023

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

("IBT" or the "Company") 

Voting Rights and Capital

In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1R the Company would like to notify the market of the following:

At the close of business on the 31 October 2023, the Company had 41,383,817 Ordinary shares in issue, of which 2,290,210 were held in Treasury. Therefore, the total number of voting rights in the Company was 39,093,607.

The above figure (39,093,607) may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information contact:

Company Secretary - Link Company Matters

Indu Shastri     +44 (0)7936 045789

LEI: 213800N1QUJ744P76D11

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TVREAXEFDEFDFFA

Talk to a Data Expert

Have a question? We'll get back to you promptly.